HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brestle named Council Chairman

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder COO Daniel J. Brestle named chairman of the Personal Care Products Council, replacing Marc Pritchard, Procter & Gamble president, global strategy, during the 2008 annual meeting in Boca Raton, Fla. In his inaugural speech, Brestle stressed the importance of supporting consumer confidence in the personal care industry, the critical role effective self-regulation plays in ensuring product safety and supplementing the work of FDA. Outgoing Chairman Pritchard spoke as well, highlighting the Council's achievements and expressing gratitude over the opportunity to preside over the organization. Separately, the Council elected Laurent Attal, president and CEO of L'Oreal USA, William J. Gentner, President and CEO of KAO Brands and Bradley Casper, president and CEO of Dial, as vice chairmen. Elizabeth Arden Chairman and CEO E. Scott Beattie was named treasurer, and Elysee Scientific Cosmetics President Linda R. Marshall was elected secretary of the Council...

You may also be interested in...

Warning Letter Close-Outs – March 2020

The US FDA released five device-related close-out letters in March.

Medicines Must Be Designated As Priority Items, Says IGBA

Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.

COVID-19: FDA Will Hold Remote Meetings With Firms, Extends Marketing Application Due Dates

In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts